Erlocip 150mg

What is Erlocip 150mg?

Erlocip 150mg is an Indian brand of erlotinib, a kinase inhibitor cancer medicine. Each tablet contains erlotinib 150 mg. It is made in India by Cipla Limited.

What it is used for

According to the US FDA label for erlotinib tablets (DailyMed), erlotinib is used for metastatic non small cell lung cancer with EGFR exon 19 deletions or exon 21 (L858R) mutations confirmed by an approved test, and, together with gemcitabine, first line treatment of locally advanced, unresectable or metastatic pancreatic cancer. Your doctor decides whether it suits you.

Packs and price

Erlocip 150mg comes in packs of 30, 60 and 90 tablets. The lowest price works out at about $6.10 per tablet on the 90 tablet pack, as of October 2026; the pack selector shows the current price. Shipping is $25 on orders under $149 and free from $149.

Prescription status

Erlotinib is a prescription medicine in the US, UK and Canada. Erlocip 150mg itself is an India made pack and is not approved by the FDA, MHRA, TGA or Health Canada. The FDA says that importing unapproved medicines for personal use is illegal in most circumstances, so check the rules where you live.

Before you order

Read the patient leaflet that comes with the pack. Tell your doctor or pharmacist about any other medicines you take and any health conditions you have. Get urgent medical help if you notice signs of an allergic reaction, such as swelling of the face, lips, tongue or throat, trouble breathing, or a widespread rash.

Delivery

Orders usually arrive in 7 to 14 business days in plain packaging, with a tracking number.